Quantitative Assessment of Response to Long‐Term Treatment with Intravenous Immunoglobulin in Patients with Stiff Person Syndrome

BACKGROUND: Stiff person syndrome (SPS) is an autoimmune condition involving antibodies against several components of the inhibitory synapse in the spinal cord, with glutamic acid decarboxylase antibodies being the predominant immune marker. SPS affects approximately 1 patient per million population...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Smriti, Thompson, Joseph P., Sadalage, Girija, Karim, Abid, Jacob, Saiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354084/
https://www.ncbi.nlm.nih.gov/pubmed/34401404
http://dx.doi.org/10.1002/mdc3.13261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354084/
https://www.ncbi.nlm.nih.gov/pubmed/34401404
http://dx.doi.org/10.1002/mdc3.13261

Ejemplares similares